Humana Inc. (NYSE:HUM) Shares Sold by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. decreased its holdings in shares of Humana Inc. (NYSE:HUM - Free Report) by 30.4% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 16,511 shares of the insurance provider's stock after selling 7,217 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.'s holdings in Humana were worth $4,189,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also made changes to their positions in the company. Vanguard Group Inc. increased its holdings in Humana by 15.8% in the 4th quarter. Vanguard Group Inc. now owns 12,829,210 shares of the insurance provider's stock valued at $3,254,899,000 after acquiring an additional 1,751,857 shares during the last quarter. Dodge & Cox boosted its position in Humana by 106.7% in the 4th quarter. Dodge & Cox now owns 10,198,040 shares of the insurance provider's stock valued at $2,587,345,000 after buying an additional 5,264,045 shares during the period. Pzena Investment Management LLC boosted its position in Humana by 44.0% in the 4th quarter. Pzena Investment Management LLC now owns 3,609,382 shares of the insurance provider's stock valued at $915,736,000 after buying an additional 1,103,132 shares during the period. Geode Capital Management LLC boosted its position in Humana by 2.3% in the 4th quarter. Geode Capital Management LLC now owns 2,883,614 shares of the insurance provider's stock valued at $729,658,000 after buying an additional 63,562 shares during the period. Finally, Invesco Ltd. boosted its position in Humana by 29.8% in the 4th quarter. Invesco Ltd. now owns 2,397,808 shares of the insurance provider's stock valued at $608,348,000 after buying an additional 550,692 shares during the period. Institutional investors own 92.38% of the company's stock.

Analyst Ratings Changes

Several equities research analysts have issued reports on the stock. Mizuho boosted their price objective on shares of Humana from $305.00 to $316.00 and gave the company an "outperform" rating in a research report on Wednesday, April 9th. Truist Financial lowered their price target on shares of Humana from $325.00 to $305.00 and set a "hold" rating for the company in a research report on Monday, May 12th. Morgan Stanley lowered their price target on shares of Humana from $301.00 to $285.00 and set an "equal weight" rating for the company in a research report on Wednesday, February 12th. Cantor Fitzgerald reaffirmed a "neutral" rating and issued a $290.00 price target on shares of Humana in a research report on Thursday, May 1st. Finally, Robert W. Baird upped their price target on shares of Humana from $270.00 to $300.00 and gave the stock a "neutral" rating in a research report on Tuesday, April 15th. Seventeen analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus target price of $286.81.

Humana Stock Performance

HUM traded down $19.60 during trading on Thursday, hitting $226.17. The stock had a trading volume of 3,003,913 shares, compared to its average volume of 1,781,673. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 1.76. The firm has a market capitalization of $27.30 billion, a P/E ratio of 22.73, a PEG ratio of 2.05 and a beta of 0.49. The company's 50-day moving average price is $262.84 and its 200 day moving average price is $269.22. Humana Inc. has a twelve month low of $212.45 and a twelve month high of $406.46.

Humana (NYSE:HUM - Get Free Report) last posted its quarterly earnings results on Wednesday, April 30th. The insurance provider reported $11.58 earnings per share for the quarter, topping analysts' consensus estimates of $10.07 by $1.51. The business had revenue of $32.11 billion for the quarter, compared to analysts' expectations of $32 billion. Humana had a net margin of 1.02% and a return on equity of 11.70%. The business's revenue for the quarter was up 8.4% on a year-over-year basis. During the same period in the prior year, the company posted $7.23 EPS. On average, equities research analysts forecast that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Friday, June 27th will be issued a dividend of $0.885 per share. The ex-dividend date of this dividend is Friday, June 27th. This represents a $3.54 annualized dividend and a dividend yield of 1.57%. Humana's payout ratio is currently 25.04%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.